Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Different Frequency Applications of Transcutaneous Auricular Vagus Nerve Stimulation in Healthy Individuals

NCT: NCT07526402 · NOT_YET_RECRUITING

NCT IDNCT07526402
StatusNOT_YET_RECRUITING
Start Date2026-05-01
Completion2026-09-01

Brief Summary

This randomized, participant-blinded, sham-controlled crossover study aims to investigate the acute effects of different frequency applications of transcutaneous auricular vagus nerve stimulation (taVNS) on autonomic physiological responses in healthy adults. Participants will receive sham (0 Hz), 10 Hz, 25 Hz, 50 Hz, and 100 Hz taVNS in separate sessions with washout periods between visits. Heart rate variability, blood pressure, pulse rate, respiratory rate, and subjective discomfort will be assessed before and after each intervention session.

Frequently Asked Questions

What is Different Frequency Applications of Transcutaneous Auricular Vagus Nerve Stimulation in Healthy Individuals?

Different Frequency Applications of Transcutaneous Auricular Vagus Nerve Stimulation in Healthy Individuals is a clinical trial registered under NCT07526402. Current status: NOT_YET_RECRUITING.

What is the status of NCT07526402?

The current status of NCT07526402 (Different Frequency Applications of Transcutaneous Auricular Vagus Nerve Stimulation in Healthy Individuals) is: NOT_YET_RECRUITING.

When did Different Frequency Applications of Transcutaneous Auricular Vagus Nerve Stimulation in Healthy Individuals start?

Different Frequency Applications of Transcutaneous Auricular Vagus Nerve Stimulation in Healthy Individuals started on 2026-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑